President Trump to Announce Nationwide Medicaid Drug Pricing Program
President Donald Trump is set to announce that all 50 states will join a Medicaid drug pricing program aimed at reducing the net price of selected drugs.
Rockford, IL, September 18, 2026 —
President Donald Trump is preparing to announce a significant initiative involving all 50 U.S. states. The program, focused on Medicaid drug pricing, is intended to lower the net cost of specific prescription medications. Details regarding the exact date of the announcement and the operational framework of this nationwide program were not immediately available.
The initiative aims to address the prices paid for selected drugs within the Medicaid system. While the objective is to reduce the net price, the specific mechanisms by which this reduction will be achieved, the types of drugs that will be included, and the projected impact on drug manufacturers and consumers remain to be fully detailed. The scope of the program encompasses all 50 states, indicating a broad federal effort to standardize or influence drug pricing across the country under Medicaid.
Information regarding the specific leadership or agencies within the administration spearheading this program, beyond the President’s announcement, has not been disclosed. Similarly, the timeline for the program’s implementation or any pilot phases has not been provided. The announcement is anticipated to outline the core components of the pricing strategy and the steps states will be asked to take to participate. Further details are expected following the official declaration.
Story summarized from the original created by FATIMA HUSSEIN, Associated Press on www.mystateline.com, see more information here.
Media gallery
